Yifan Li

China

Dr Li has ertise in management and passion in improving the prognosis and quality of life of patients of gastric cancer.

Member of Shanxi Anti-Cancer Association.

Derek Roger Wilke

Canada

Dr. Derek R Wilke is a Radiation Oncologist, at Dalhousie University, Nova Scotia Health, in Halifax, Nova Scotia Cancer. His research interests include outcomes in Head and neck cancer, Lymphoma and cancers of the genito-urinary tract, as well as statistical modelling and analysis, measurement of quality of life and adaptive radiotherapy.

Mohamed El-Far

Egypt

Professor Mohamed El-Far, worked in biochemistry field for 40 years, published over 100 peer-reviewed papers. He received Fulbright and British council fellowships several times as well as German DAAD grant to establish PDT Program at Munich, also received US-AID grant to establish PDT unit in Egypt. He is serving on the editorial boards and Hon. Editor to four international journals. He acts as UNESCO expert in science and technology. Dr. El-Far served as visiting professor to University of California as well as Utah laser center also Mayo clinic for several years. He also served as a visiting professor to Cardiff and Swansea Universities, UK. He is a member of International Photodynamic Association and Royal Society of Chemistry, UK. Selected and served as expert and consultant for biochemistry in the national committee of suprime council of Universities in Egypt, which is the highest nation honor. Selected as a member of higher Education and Research committee for Mansoura University. Selected by the International Biographical Centre, Cambridge, England to be among top 100 scientists 2012. Received honary doctorate of Letters from International Biographical Centre, Cambridge, England. Selected on the list of global speakers as chairman, a keynote speaker and honorable guest for several international conferences in cancer and diabetes as well as other recent biomedical applications as stem cells and nanotechnology. Selected as Mansoura university person of the year 2017 / 2018 and awarded certificate of recognition and Mansoura University's shield. Dr. El-Far is an international expert in photodynamic therapy (PDT), he is the first worldwide to use sildenafil as novel antiabortive agent. Dr. El-Far was selected by Royal Swedish Academy of Science to nominate Nobel Prize winners in chemistry for year 2021 which is most prestigious honor in the world.

Shunfu Hu

USA

Dr. Shunfu Hu is a Professor of Geography and Geograohic Information Sciences, Southern Illinois University Edwardsville, USA. He has recently worked on public health data sets for the purpose of visualizing the spatiotemporal patterns of the morality rates of many diseases, including cancer.

Thomas Boldicke

Germany

Associate Professor Thomas Böldicke received his PhD 1982 at the Max-Planck-Institut of Molecular Genetics, Berlin. He started his carrier as post doc at the German Research Centre for Biotechnology (GBF, Braunschweig, Germany) in the Department of Genetics and Cell Biology by John Collins. Now he is senior scientist at the Helmholtz Centre for Infection Research (HZI, former GBF) and project leader intrabodies. He developed recombinant antibodies against tumour antigens, particularly against tumour angiogenesis, rhabdyomyosarcom and recently against TLR2 and TLR9 in pancreatic cancer. He edited two books: “Protein Targeting Compounds” with Springer (2016) and “Antibody Engineering” with IntechOpen (2017). He has published 35 manuscripts. Over 10 years he gave lectures at the Technical University in Braunschweig about immunology, cancer development and immunotherapies. He is in the editorial board of the journal Antibodies as academic editor, Frontiers in Immunology and Frontiers in Oncology.

Pedro Fonte

Portugal

Pedro Fonte is an Assistant Professor at the Faculty of Sciences and Technology, University of Algarve, Portugal. He is an Integrated Member of the Center for Marine Sciences (CCMAR) at the University of Algarve and a Collaborative Researcher at the Institute for Bioengineering and Biosciences (iBB) at Instituto Superior Técnico, University of Lisbon.

He has expertise on developing cutting-edge nanocarriers for drug delivery. His research is dedicated to pioneering targeted and controlled drug delivery systems that effectively cross biological barriers, enhancing treatment precision and efficacy. He is also a specialist in the lyophilization and solid-state characterization of pharmaceuticals and biopharmaceuticals, ensuring the stability and bioactivity of drugs. Moreover, his expertise extends to the structural characterization of therapeutic proteins, vital for advancing biopharmaceutical innovations. Currently, his groundbreaking work is primarily focused on revolutionary applications in cancer treatment and wound healing.

Pedro Fonte has successfully coordinated several funded scientific projects, establishing valuable collaborations with researchers and academics worldwide. His publication record includes over 50 papers in high-impact peer-reviewed journals, 10 book chapters, and 1 edited book. His contributions to the scientific community and society have garnered him many awards and distinctions, including recognition as one of the Top 2% Scientists by Stanford University.

Anne-Catherine Prats

France

Anne-Catherine PRATS has international reputation in the field of RNA and translational control, and received several scientific prizes. She has focused on the role of mRNA IRESs, non-coding RNAs and RNA-binding proteins in the control of gene expression in stress conditions. She has studied the impact of these molecular mechanism in cancer development as well as in cardiovascular diseases. ACP is also an expert in vectorology and gene therapy and is presently focusing on lymphedema gene therapy in the THERALYMPH European consortium.